Skip to main content
OpenTrials
Completed

NCT Number: NCT04219878

Implementation of Rapid HIV Self-Testing Among MSM Project

This study will use online materials and strategies to recruit 3600 Black and Hispanic men who have sex with men (MSM) and transgender women (TGW) to participate in a study evaluating the effectiveness of the Know@Home mobile app compared to control condition with respect to linkage of participants to appropriate services, as well as cost-effectiveness outcomes.

Completed

Looking for future studies?

Notify Me

Key information

About this study

To evaluate the effectiveness of mailing out rapid HIV home-testing kits and additional testing promotion components among African-American or black and Hispanic or Latino gay, bisexual, and other men who have sex with men (MSM) and transgender women (TGW), the study "Implementation of Rapid HIV Self-Testing among MSM Project", known as iSTAMP, is being conducted in 11 US states. This study is interested in the most cost-effective ways to recruit people at high risk for HIV infection. The researchers want to study a sample of 3600 adult MSM and TGW who are not known to be living with HIV; 1800 black/African-American and 1800 Hispanic/Latino participants will be enrolled.

All participants will be mailed two rapid HIV self-test kits upon randomization. All participants, regardless of study arm, will also complete a follow-up survey at the end of a 4-month follow-up period. At the end of the 4-month follow-up period, participants will be mailed a dried blood spot (DBS) collection kit for research purposes, as well as another rapid HIV self-test kit for immediate testing. Participants in each of the arms will have access to videoconferencing-delivered prevention counseling, and all participants, regardless of assigned arm, will be contacted if they report seroconversion and/or a preliminary positive test during the study period for active linkage to care.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

for MSM Participants:

  • Black/African-American race or Hispanic/Latino ethnicity
  • Male sex at birth
  • Currently identify as male
  • Reported anal sex with at least one man in the past 12 months
  • Aged 18 or over
  • Has an Android or Apple mobile phone with currently active service
  • Currently resides in a study state: North Carolina, South Carolina, Georgia, Alabama, Mississippi, Florida, Louisiana, California, Nevada, Texas, New York
  • Willing to download a study participation management mobile app
  • Willing to provide valid contact information so that study HIV testing kits and other materials (condoms, lubricants, STI testing kits) can be mailed to participants.
  • Successful completion of baseline survey

Exclusion criteria

for MSM Participants:

  • Currently participating in another HIV prevention research study or program
  • Has a bleeding disorder preventing use of dried blood spot testing
  • Has previously participated in an HIV vaccine study.
  • Currently taking PrEP for HIV prevention
  • Self-reports living with HIV
  • Has plans to move out of a study state during the study period (4 months)

Inclusion criteria

for TGW:

  • Male sex at birth
  • Currently identify as transgender woman or female
  • Aged 18 or over
  • Has an Android or Apple mobile smartphone with currently active service
  • Currently resides in a study state: North Carolina, South Carolina, Georgia, Alabama, Mississippi, Florida, Louisiana, California, Nevada, Texas, New York
  • Willing to provide valid contact information so that study HIV testing kits and other materials (condoms, lubricants, STI testing kits) can be mailed to participants
  • Successful completion of baseline survey

Exclusion criteria

for TGW:

  • Currently participating in another HIV prevention clinical trial or intervention
  • Has a bleeding disorder preventing use of dried blood spot testing
  • Has previously participated in an HIV vaccine study
  • Currently taking PrEP for HIV prevention
  • Self-reports living with HIV
  • Has plans to move out of a study state during the study period (4 months)

Treatment and study plan

Know@Home

Behavioral

Participants randomly assigned to the Know@Home arm will access the features of Know@Home by downloading the app or accessing the website. The contents were developed to serve as a comprehensive mobile HIV prevention platform for MSM or TGW, with HIV prevention and care information and links to resources. This intervention arm provides an toolkit that allows users to access information about prevention services as their needs change. Participants will have access to Know@Home for the study period. The Know@Home arm will offer participants the opportunity to order free condoms and lubricant as well as an at-home sexually transmitted infection (STI) testing kit.

Self-test Kit

Other

All participants will be shipped two at-home HIV self-tests. They will also receive a link to a previously-produced video that fully describes the specimen collection process, pointing out common errors and providing tips for successful collection. Participants will interact with study staff through phone, email, or text. Information to schedule a video HIV testing and counseling session with study staff will be made available to participants in all arms via a website, email, and/or text.

Other names: OraQuick® In-Home HIV Test

Primary outcomes

  1. Number of participants initiating HIV treatment

    Time frame: Up to Month 4

    Effectiveness of the interventions will be assessed by linkage of participants to HIV treatment.

  2. Number of participants initiating PrEP treatment

    Time frame: Up to Month 4

    Effectiveness of the interventions will be assessed by linkage of participants to PrEP treatment.

  3. Number of participants testing for STIs

    Time frame: Up to Month 4

    Effectiveness of the interventions will be assessed by linkage of participants to STI testing.

  4. Number of participants engaging in HIV prevention services

    Time frame: Up to Month 4

    Effectiveness of the interventions will be assessed by linkage of participants to HIV prevention services.

  5. Number of participants engaging in HIV social services

    Time frame: Up to Month 4

    Effectiveness of the interventions will be assessed by linkage of participants to HIV social services.

  6. Cost of different online venues for study enrollment

    Time frame: Baseline

    Enrollment in the study defined as completion of the baseline survey and downloading of the study app. The cost (in US dollars) to enroll participants (online banner advertisement placement, study staff time to manage enrollment, validating participant eligibility, monitoring and evaluation of enrollment data) will be compared between the study arms.

  7. Cost of different online venues for HIV test results returned

    Time frame: Month 1

    The cost (in US dollars) of HIV tests returned within 1 month of enrollment will be compared between the study arms. The costs involved with having HIV tests returned include:

    • Online banner advertisement placement
    • Study staff time managing enrollment, validating participant eligibility, monitoring and evaluation of enrollment data
    • HIV test kits
    • Shipping for HIV test kits
    • Staff/personnel time to manage mailing/return of test kits
    • Other general and administrative time, office supplies, equipment, rents, utilities
  8. Cost of different online venues for identifying new HIV diagnoses

    Time frame: Month 1

    The cost (in US dollars) of identifying established HIV infections will be compared between the study arms. The costs involved with identifying established HIV infections include:

    • Online banner advertisement placement
    • Study staff time managing enrollment, validating participant eligibility, monitoring and evaluation of enrollment data
    • HIV test kits
    • Shipping for HIV test kits
    • Staff/personnel time to manage mailing/return of test kits
    • Study staff time to manage monitoring and evaluation of HIV test result data
    • Study staff time to provide phone counseling to those with established infections
    • Other general and administrative time, office supplies, equipment, rents, utilities

Secondary outcomes

  1. Cost of linkage to HIV counseling

    Time frame: Month 4

    The cost (in US dollars) of linking participants testing positive for HIV to HIV counseling will be compared between the study arms, including:

    • Study staff time spent contacting participants
    • Study staff time for intervention maintenance (e.g., app management)
    • HIV counseling costs to the healthcare system
    • Other general and administrative time, office supplies, equipment, rents, utilities
  2. Cost of linkage to HIV treatment

    Time frame: Month 4

    The cost (in US dollars) of linking participants testing positive for HIV to HIV treatment will be compared between the three study arms, including:

    • Study staff time for intervention maintenance (e.g., app management)
    • HIV treatment costs to the healthcare system
    • Other general and administrative time, office supplies, equipment, rents, utilities
  3. Cost of linkage to PrEP counseling

    Time frame: Month 4

    The cost (in US dollars) of linking participants testing negative for HIV to PrEP counseling will be compared between the study arms, including:

    • Study staff time contacting participants
    • Study staff time for intervention maintenance (e.g., app management)
    • PrEP counseling costs to the healthcare system
    • Other general and administrative time, office supplies, equipment, rents, utilities
  4. Cost of linkage to PrEP uptake

    Time frame: Month 4

    The cost (in US dollars) of linking participants testing negative for HIV to initiate PrEP treatment will be compared between the study arms, including:

    • Study staff time contacting participants
    • Study staff time for intervention maintenance (e.g., app management)
    • PrEP uptake costs to the healthcare system
    • Other general and administrative time, office supplies, equipment, rents, utilities
  5. Cost of Sexually Transmitted Infection (STI) testing

    Time frame: Month 4

    The cost (in US dollars) of providing at-home STI testing be compared between the study arms, including:

    • Cost of STI testing materials and shipping
    • Laboratory STI testing
    • Study staff time processing orders and contacting participants
    • Study staff time for intervention maintenance (e.g., app management)
    • STI testing costs to the healthcare system
    • Other general and administrative time, office supplies, equipment, rents, utilities
  6. Cost of linkage to STI treatment

    Time frame: Month 4

    The cost (in US dollars) of providing treatment for STIs discovered through at-home STI testing be compared between the three study arms, including:

    • Study staff time processing orders and contacting participants
    • Study staff time for intervention maintenance (e.g., app management)
    • STI treatment costs to the healthcare system
    • Other general and administrative time, office supplies, equipment, rents, utilities

Sponsors and collaborators

Lead sponsor

Emory University

Other

Collaborators

  • Centers for Disease Control and Prevention

Registry information

Official study title

Engaging African American and Hispanic/Latino MSM for HIV Testing and Prevention Services Through Technology

Acronym: iSTAMP

Important dates

Study start
2020
Primary completion
2021
Study completion
2022
First posted
Jan 7, 2020
Registry last updated
Feb 1, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.